Enalapril Maleate Tablet, USP 5mg 30 Tablet bottle, Rx, Apace Packaging LLC, Ft. Run, KY 42133, N...

FDA Drug Recall #D-1683-2012 — Class III — September 4, 2012

Recall Summary

Recall Number D-1683-2012
Classification Class III — Low risk
Date Initiated September 4, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Apace KY LLC
Location Fountain Run, KY
Product Type Drugs
Quantity 81,516 bottles

Product Description

Enalapril Maleate Tablet, USP 5mg 30 Tablet bottle, Rx, Apace Packaging LLC, Ft. Run, KY 42133, NDC 15338-211-30

Reason for Recall

Labeling Illegible: Some bottles labels have incomplete NDC numbers and missing strength.

Distribution Pattern

Nationwide

Lot / Code Information

Lot: DL11600 Exp Date: 06/13

Other Recalls from Apace KY LLC

Recall # Classification Product Date
D-0544-2018 Class II Acyclovir Tablets, USP, 400 mg, 50 Tablets (5 x... Feb 9, 2018
D-1035-2017 Class II Amantadine HCl Capsules, USP, 100 mg, Rx Only, ... Jun 19, 2017
D-1036-2017 Class II Cyclobenzaprine HCl Tablets, USP, 5 mg, 50 Tabl... Jun 19, 2017
D-0811-2016 Class III Minocycline Hydrochloride Capsules USP, 100 mg*... Feb 12, 2016

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.